J&J, other drugmakers to face trial in California over claims they fueled opioid epidemic reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
Provided by Dow Jones
By Sara Randazzo Four drugmakers are slated to go on trial Monday in California over claims they fed the opioid crisis, in a proceeding that could help finalize multibillion-dollar settlements between state and local governments and pharmaceutical companies. The case is just the second to go to trial out of thousands of similar lawsuits accusing the drug industry of fueling an opioid epidemic that has killed nearly 500,000 people since 1999, according to federal data. In the trial set to begin Monday fully by videoconference, four California communities allege that Johnson & Johnson, Teva Pharmaceutical Ltd., Allergan and Endo International PLC ran misleading marketing campaigns that played down the risks of opioid addiction to boost sales of powerful prescription painkillers.
$50B Opioid Trial Begins Monday In California, CVN To Webcast On Demand Gavel-to-Gavel
stock image of opioid medication
Santa Ana, CA - Four major pharmaceutical companies go to trial on Monday in California state court over allegations that their marketing of prescription painkillers contributed to the ongoing opioid addiction crisis, and the proceedings will be webcast gavel-to-gavel by Courtroom View Network.
Johnson & Johnson, Teva Pharmaceutical Industries, Endo International and AbbVie face accusations in a civil lawsuit filed by Santa Clara, Los Angeles and Orange Counties and the City of Oakland that they aggressively marketed opioid-based painkillers while downplaying the risk of addiction. The lawsuit seeks $50 billion in damages.
By Syndicated Content
By Nate Raymond and Brendan Pierson
(Reuters) - Four drugmakers, including Johnson & Johnson and Teva Pharmaceutical Industries Ltd, will go to trial on Monday over claims they helped fuel an opioid crisis that has resulted in nearly 500,000 overdose deaths in the United States.
The trial is one of several looking to hold companies accountable for the overdose and abuse crisis that are set to take place this year after the coronavirus pandemic delayed litigation, putting renewed pressure on them to enter into multi-billion dollar settlements.
J&J, Teva Pharmaceutical Industries Ltd, Endo International PLC and Abbvie s Allergan unit are accused by several California counties of deceptively marketing painkillers in ways that downplayed their addictive risks to boost sales.